Beta Bionics, Inc Common Stock

Yahoo Finance • 4 days ago

Lowest Quant ranked small-cap stocks with positive EPS surprises

[Wall street sign on manhattan] franckreporter/iStock via Getty Images With the Q4 earnings season almost coming to an end, below is a list of small-cap stocks with positive quarterly EPS surprises ranked according to their lowest Seeking... Full story

Yahoo Finance • 4 days ago

Beta Bionics, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

BOSTON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Beta Bionics, Inc. (Nasdaq: BBNX) for potential securities law violations. Investors who have lost money in their Beta Bionics, Inc. investment should contact the... Full story

Yahoo Finance • 11 days ago

BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Aquestive Therapeutics To Contact Him Directly To Discuss Their Options If you suffered significant losses in B... Full story

Yahoo Finance • 12 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beta Bionics, Inc. - BBNX

NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX).  Such investors are advised to contact Danielle Peyton at n... Full story

Yahoo Finance • 12 days ago

Beta Bionics GAAP EPS of -$0.30 beats by $0.10, revenue of $32.1M beats by $1.03M

* Beta Bionics press release [https://seekingalpha.com/pr/20402602-beta-bionics-announces-fourth-quarter-and-full-year-2025-financial-results-and-introduces] (BBNX [https://seekingalpha.com/symbol/BBNX]): Q4 GAAP EPS of -$0.30 beats by $... Full story

Yahoo Finance • 21 days ago

Oracle gets upgrade and downgrade: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Roth Capital upgraded Roblox (RBLX) to... Full story

Yahoo Finance • 26 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Beta Bionics, Inc. - BBNX

NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX).  Such investors are advised to contact Danielle Peyton at n... Full story

Yahoo Finance • 3 months ago

Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026

IRVINE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to pre-release its topli... Full story

Yahoo Finance • 3 months ago

BBNX Crosses Above Average Analyst Target

In recent trading, shares of Beta Bionics Inc (Symbol: BBNX) have crossed above the average analyst 12-month target price of $31.30, changing hands for $31.34/share. When a stock reaches the target an analyst has set, the analyst logicall... Full story

Yahoo Finance • 4 months ago

Beta Bionics raises 2025 revenue guidance to $96.5M and projects Q4 gross margin improvement amid pharmacy channel expansion

Earnings Call Insights: Beta Bionics, Inc. (BBNX) Q3 2025 MANAGEMENT VIEW * CEO Sean Saint opened the call by highlighting "strong performance in the third quarter" and updated annual projections for 2025. He cited record new patient s... Full story

Yahoo Finance • 4 months ago

Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance

IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended September 3... Full story

Yahoo Finance • 6 months ago

7 Biotech Stocks Trading At 52-Week Highs - Can The Rally Continue?

(RTTNews) - Patience is a virtue - important in all aspects of life, and especially crucial when it comes to investing. As trading expert Steve Burns once said, "Much of our trading comes down to a battle between our patience and our impul... Full story

Yahoo Finance • 7 months ago

Beta Bionics Inc (NASDAQ:BBNX) Surpasses Q2 2025 Estimates and Raises Full-Year Guidance

Beta Bionics Inc (NASDAQ:BBNX [https://www.chartmill.com/stock/quote/BBNX/profile]) reported its second-quarter 2025 financial results, surpassing analyst expectations for both revenue and earnings per share (EPS). The company also raised... Full story

Yahoo Finance • 7 months ago

Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance

IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended June 30, 20... Full story

Yahoo Finance • 8 months ago

Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas

Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated insulin delivery/AID system with Abbott’s fut... Full story

Yahoo Finance • 8 months ago

Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025

IRVINE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its second quarter 2025 finan... Full story

Yahoo Finance • 8 months ago

Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor

Beta Bionics, Inc. IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet Bionic Pancreas autom... Full story

Yahoo Finance • 10 months ago

Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025

IRVINE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended March 31, 20... Full story

Yahoo Finance • 11 months ago

Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025

IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its first quarter 2025 finan... Full story

Yahoo Finance • 11 months ago

Beta Bionics Announces Board Appointment of Gerard Michel

IRVINE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced the appointment of Gerard Michel as an independent me... Full story